共有 50 笔近期内部人交易记录记录，涉及 Tempest Therapeutics, Inc. (TPST), 包括 46 笔买入 和 3 笔卖出. 内部人买入总额为 $16.6M 内部人卖出总额为 $989.93K.
近期活跃的重要内部人包括 Maestas Nicholas, Trojanowski Justin, Angel Matthew. 内部人交易记录可以揭示公司管理层对股票估值和未来前景的看法.
内部人交易记录 — TPST
| 日期 |
姓名 |
职位 |
交易类型 |
股数 |
平均价格 |
总价值 |
持股数量 |
| 2026-03-31 |
Maestas Nicholas |
Chief Financial Officer |
限制性股票授予 (RSU) |
140,000 |
$1.64 |
$229.6K |
140,000 |
| 2026-03-31 |
Trojanowski Justin |
Corporate Controller |
限制性股票授予 (RSU) |
22,000 |
$1.64 |
$36.08K |
22,000 |
| 2026-03-24 |
Angel Matthew |
10 Percent Owner, Officer: CEO and President |
知情买入 |
231,482 |
$2.16 |
$500K |
231,482 |
| 2026-02-04 |
Angel Matthew |
10 Percent Owner, Officer: CEO and President |
限制性股票授予 (RSU) |
269,621 |
$2.38 |
$641.7K |
269,621 |
| 2026-02-03 |
Angel Matthew |
10 Percent Owner, Officer: CEO and President |
未知 |
- |
- |
- |
8,268,495 |
| 2026-01-27 |
Pellizzari Christine A |
Director |
限制性股票授予 (RSU) |
1,230 |
$2.94 |
$3.62K |
1,230 |
| 2026-01-27 |
Nichol Geoffrey |
Director |
限制性股票授予 (RSU) |
1,230 |
$2.94 |
$3.62K |
1,230 |
| 2026-01-27 |
Raab Michael |
Director |
限制性股票授予 (RSU) |
1,230 |
$2.94 |
$3.62K |
1,230 |
| 2026-01-27 |
Simantov Ronit |
Director |
限制性股票授予 (RSU) |
1,230 |
$2.94 |
$3.62K |
1,230 |
| 2025-01-02 |
Brady Stephen R |
President and CEO |
限制性股票授予 (RSU) |
550,000 |
$0.86 |
$473K |
550,000 |
| 2025-01-02 |
Whiting Samuel |
Chief Medical Officer |
限制性股票授予 (RSU) |
270,000 |
$0.86 |
$232.2K |
270,000 |
| 2025-01-02 |
Maestas Nicholas |
Chief Financial Officer |
限制性股票授予 (RSU) |
200,000 |
$0.86 |
$172K |
200,000 |
| 2025-01-02 |
Trojanowski Justin |
Corporate Controller |
限制性股票授予 (RSU) |
30,000 |
$0.86 |
$25.8K |
30,000 |
| 2024-08-12 |
Versant Venture Capital Vi, L.p. |
10 Percent Owner |
知情卖出 |
387,999 |
$1.10 |
$426.99K |
209,941 |
| 2024-08-08 |
Versant Venture Capital Vi, L.p. |
10 Percent Owner |
知情卖出 |
400,000 |
$1.35 |
$540.04K |
597,940 |
| 2024-07-03 |
Brady Stephen R |
President and CEO |
知情买入 |
35,000 |
$2.11 |
$73.85K |
46,376 |
| 2024-07-02 |
Whiting Samuel |
Chief Medical Officer |
知情买入 |
4,672 |
$2.13 |
$9.95K |
9,573 |
| 2024-06-28 |
Trojanowski Justin |
Corporate Controller |
知情买入 |
7,500 |
$2.16 |
$16.2K |
22,168 |
| 2024-06-13 |
Pellizzari Christine A |
Director |
限制性股票授予 (RSU) |
16,000 |
$3.03 |
$48.48K |
16,000 |
| 2024-06-13 |
Nichol Geoffrey |
Director |
限制性股票授予 (RSU) |
16,000 |
$3.03 |
$48.48K |
16,000 |
| 2024-06-13 |
Raab Michael |
Director |
限制性股票授予 (RSU) |
16,000 |
$3.03 |
$48.48K |
16,000 |
| 2024-06-13 |
Simantov Ronit |
Director |
限制性股票授予 (RSU) |
16,000 |
$3.03 |
$48.48K |
16,000 |
| 2024-01-03 |
Brady Stephen R |
President and CEO |
限制性股票授予 (RSU) |
250,000 |
$4.66 |
$1.17M |
250,000 |
| 2024-01-03 |
Whiting Samuel |
Chief Medical Officer |
限制性股票授予 (RSU) |
100,000 |
$4.66 |
$466K |
100,000 |
| 2024-01-03 |
Maestas Nicholas |
VP of Strategy and Finance |
限制性股票授予 (RSU) |
40,000 |
$4.66 |
$186.4K |
40,000 |
| 2024-01-03 |
Trojanowski Justin |
Principal Accounting Officer |
限制性股票授予 (RSU) |
26,500 |
$4.66 |
$123.49K |
26,500 |
| 2023-10-11 |
Brady Stephen R |
President and CEO |
限制性股票授予 (RSU) |
725,000 |
$9.77 |
$7.08M |
725,000 |
| 2023-10-11 |
Whiting Samuel |
Chief Medical Officer |
限制性股票授予 (RSU) |
325,000 |
$9.77 |
$3.18M |
325,000 |
| 2023-10-11 |
Maestas Nicholas |
VP of Strategy and Finance |
限制性股票授予 (RSU) |
100,000 |
$9.77 |
$977K |
100,000 |
| 2023-10-11 |
Trojanowski Justin |
Corporate Controller |
限制性股票授予 (RSU) |
55,000 |
$9.77 |
$537.35K |
55,000 |
| 2023-06-15 |
Pellizzari Christine A |
Director |
限制性股票授予 (RSU) |
8,200 |
$1.42 |
$11.64K |
8,200 |
| 2023-06-15 |
Nichol Geoffrey |
Director |
限制性股票授予 (RSU) |
8,200 |
$1.42 |
$11.64K |
8,200 |
| 2023-06-15 |
Raab Michael |
Director |
限制性股票授予 (RSU) |
8,200 |
$1.42 |
$11.64K |
8,200 |
| 2023-06-15 |
Simantov Ronit |
Director |
限制性股票授予 (RSU) |
8,200 |
$1.42 |
$11.64K |
8,200 |
| 2023-01-03 |
Brady Stephen R |
Chief Executive Officer |
限制性股票授予 (RSU) |
177,300 |
- |
- |
177,300 |
| 2023-01-03 |
Dubensky Thomas W. |
President |
限制性股票授予 (RSU) |
102,700 |
- |
- |
102,700 |
| 2023-01-03 |
Whiting Samuel |
Chief Medical Officer |
限制性股票授予 (RSU) |
69,700 |
- |
- |
69,700 |
| 2023-01-03 |
Maestas Nicholas |
VP of Strategy and Finance |
限制性股票授予 (RSU) |
38,425 |
- |
- |
38,425 |
| 2023-01-03 |
Trojanowski Justin |
Corporate Controller |
限制性股票授予 (RSU) |
20,300 |
- |
- |
20,300 |
| 2022-10-03 |
Trojanowski Justin |
Corporate Controller |
限制性股票授予 (RSU) |
2,500 |
- |
- |
2,500 |
| 2022-09-30 |
Trojanowski Justin |
Corporate Controller |
处置 |
10,000 |
$2.29 |
$22.9K |
- |
| 2022-06-22 |
Whiting Samuel |
Chief Medical Officer |
限制性股票授予 (RSU) |
55,680 |
- |
- |
55,680 |
| 2022-06-21 |
Brady Stephen R |
Chief Executive Officer |
限制性股票授予 (RSU) |
173,533 |
- |
- |
173,533 |
| 2022-06-21 |
Dubensky Thomas W. |
President |
限制性股票授予 (RSU) |
87,801 |
$2.35 |
$206.33K |
87,801 |
| 2022-06-21 |
Lorenzo Pierre |
Corporate Controller |
限制性股票授予 (RSU) |
8,477 |
- |
- |
8,477 |
| 2022-06-21 |
Maestas Nicholas |
VP of Strategy and Finance |
限制性股票授予 (RSU) |
51,270 |
- |
- |
51,270 |
| 2022-06-17 |
Pellizzari Christine A |
Director |
限制性股票授予 (RSU) |
3,500 |
- |
- |
3,500 |
| 2022-06-17 |
Nichol Geoffrey |
Director |
限制性股票授予 (RSU) |
3,500 |
$2.08 |
$7.28K |
3,500 |
| 2022-06-17 |
Raab Michael |
Director |
限制性股票授予 (RSU) |
3,500 |
- |
- |
3,500 |
| 2022-06-17 |
Woiwode Thomas |
Director |
限制性股票授予 (RSU) |
3,500 |
$2.08 |
$7.28K |
3,500 |
■ 知情交易 — 公开市场买卖（最具参考价值）
■ 非知情买入 — 奖励、期权行权、转换
■ 非知情卖出 — 税务代扣、归属出售
■ 中性 — 礼赠、信托、到期
